3M India reported a 14.7% rise in revenue to Rs 1,452.49 crore, but net profit fell 17.2% to Rs 158.48 crore in Q2 FY27. Profitability was pressured by rupee depreciation and inflation. Key strategic shifts include a long-term healthcare distribution extension with Solventum.
3M India Q2 FY27: Revenue Rises 14.7%, Profit Declines 17.2%
Revenue for Q2 FY27 stood at Rs 1,452.49 crore, while Profit After Tax (PAT) came in at Rs 158.48 crore.
Reader Takeaway: Strong double-digit top-line growth across segments is currently offset by margin pressure from currency depreciation and inflation.
What just happened
3M India reported mixed financial results for the quarter ending September 2026. While the company achieved healthy revenue growth of 14.7% compared to the previous year, its bottom line suffered a 17.2% contraction. EBITDA fell by 12.7% to Rs 234 crore as external macroeconomic headwinds squeezed margins.
Why this matters
The company’s ability to grow sales across all four core segments—Transportation & Electronics (23.4%), Consumer (19.5%), Safety & Industrial (11.8%), and Health Care (4.1%)—indicates strong demand. However, the decline in PAT highlights how sensitive the company's profitability is to rupee volatility and rising input costs linked to global supply chain challenges.
Strategic Developments
3M India has secured its healthcare business trajectory by extending its distribution partnership with Solventum until March 31, 2031. Additionally, the company is transitioning its Purification & Filtration (P&F) portfolio distribution rights to Thermo Fisher, a move that will likely reshape its operational footprint in the coming quarters.
Board and Governance Update
There has been a leadership transition in the boardroom. Mr. Chun Hao Lok has been appointed as an Additional Director (Non-Executive, Non-Independent) effective November 7, 2026. This follows the resignation of Ms. Kong Sau Wai Elizabeth, who stepped down from her position as a Non-Executive Director to pursue other professional opportunities.
Risks to watch
Investors should monitor the persistence of inflationary pressures and currency risks. If the rupee continues to weaken, further margin erosion could occur. The successful transition of the P&F portfolio to Thermo Fisher remains a key operational milestone to watch.
What to track next
The market will look for signs of margin recovery in subsequent quarters and updates on the progress of the transition of distribution rights to Thermo Fisher.